# SeaStar Medical (ICU) — Earnings

ICU · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/icu/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.91 |
| EPS estimate | −$0.97 |
| EPS surprise | +6.19% |
| Revenue surprise | +26.41% |
| Revenue | $615,000.00 |
| Revenue estimate | $486,500.00 |
| Reported | Aug 12, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1831868/000143774926027353/icu20260630_10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/bdccdfdc-ac07-8816-c206-b92b0aea2bdc.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 12, 2026 | −$0.97 | −$0.91 | 6.19% | $486,500.00 | $615,000.00 |
| Q1 2026 | May 13, 2026 | −$0.83 | −$0.90 | -9.09% | $437,500.00 | $495,000.00 |
| Q4 2025 | Mar 25, 2026 | −$1.08 | −$0.80 | 25.93% | $222,500.00 | $420,000.00 |
| Q3 2025 | Nov 13, 2025 | −$0.15 | −$0.13 | 13.33% | $250,000.00 | $183,000.00 |
| Q2 2025 | Aug 13, 2025 | −$0.43 | −$0.18 | 58.14% | $200,000.00 | $338,000.00 |
| Q1 2025 | May 14, 2025 | −$0.52 | −$0.44 | 15.38% | $150,000.00 | $293,000.00 |
| Q4 2024 | Mar 27, 2025 | −$0.89 | −$0.90 | -1.12% | $150,000.00 | $67,000.00 |
| Q3 2024 | Nov 13, 2024 | −$1.13 | −$1.10 | 2.65% | $75,000.00 | $68,000.00 |
| Q2 2024 | Aug 13, 2024 | −$1.41 | −$1.03 | 26.95% | — | — |
| Q1 2024 | May 14, 2024 | −$3.75 | −$4.75 | -26.67% | $150,000.00 | — |
| Q4 2023 | Apr 16, 2024 | −$3.25 | −$4.75 | -46.15% | $175,000.00 | — |
| Q3 2023 | Nov 14, 2023 | −$6.25 | −$9.25 | -48.00% | $50,000.00 | — |
| Q2 2023 | Aug 14, 2023 | −$6.25 | −$6.25 | 0.00% | — | — |
| Q1 2023 | May 15, 2023 | −$5.00 | −$10.00 | -100.00% | — | — |

## Frequently Asked Questions

### When did SeaStar Medical (ICU) last report earnings?

SeaStar Medical last reported on Aug 12, 2026, covering fiscal Q2 2026.

### Did ICU beat earnings estimates?

Yes. SeaStar Medical reported EPS of −$0.91 for Q2 2026 against a −$0.97 estimate — a 6.19% beat.

### How much revenue did ICU report last quarter?

SeaStar Medical reported $615,000.00 in revenue for Q2 2026, against a consensus estimate of $486,500.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).